Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia

Shigeo Kure, Kumi Kato, Agirios Dinopoulos, Chuck Gail, Ton J. DeGrauw, John Christodoulou, Vladimir Bzduch, Rozalia Kalmanchey, G. Fekete, Alex Trojovsky, Barbara Plecko, Galen Breningstall, Jun Tohyama, Yoko Aoki, Yoichi Matsubara

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Nonketotic hyperglycinemia (NKH) is an inborn error of metabolism characterized by accumulation of glycine in body fluids and various neurological symptoms. NKH is caused by deficiency of the glycine cleavage multi-enzyme system with three specific components encoded by GLDC, AMT and GCSH. We undertook the first comprehensive screening for GLDC, AMT and GCSH mutations in 69 families (56, six, and seven families with neonatal, infantile, and late-onset type NKH, respectively). GLDC or AMT mutations were identified in 75% of neonatal and 83% of infantile families, but not in late-onset type NKH. No GCSH mutation was identified in this study. GLDC mutations were identified in 36 families, and AMT mutations were detected in 11 families. In 16 of the 36 families with GLDC mutations, mutations were identified in only one allele despite sequencing of the entire coding regions. The GLDC gene consists of 25 exons. Seven of the 32 GLDC missense mutations were clustered in exon 19, which encodes the cofactor-binding site Lys754. A large deletion involving exon 1 of the GLDC gene was found in Caucasian, Oriental, and black families. Multiple origins of the exon 1 deletion were suggested by haplotype analysis with four GLDC polymorphisms. This study provides a comprehensive picture of the genetic background of NKH as it is known to date.

Original languageEnglish
Pages (from-to)343-352
Number of pages10
JournalHuman Mutation
Volume27
Issue number4
DOIs
Publication statusPublished - Apr 2006

Fingerprint

Nonketotic Hyperglycinemia
Mutation
Exons
Glycine
Inborn Errors Metabolism
Body Fluids
Missense Mutation
Haplotypes
Genes
Alleles
Binding Sites

Keywords

  • AMT
  • GCSH
  • Genotype-phenotype
  • GLDC
  • Glycine cleavage system
  • Glycine encephalopathy
  • Mutation spectrum
  • NKH
  • Nonketotic hyperglycinemia

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Kure, S., Kato, K., Dinopoulos, A., Gail, C., DeGrauw, T. J., Christodoulou, J., ... Matsubara, Y. (2006). Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia. Human Mutation, 27(4), 343-352. https://doi.org/10.1002/humu.20293

Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia. / Kure, Shigeo; Kato, Kumi; Dinopoulos, Agirios; Gail, Chuck; DeGrauw, Ton J.; Christodoulou, John; Bzduch, Vladimir; Kalmanchey, Rozalia; Fekete, G.; Trojovsky, Alex; Plecko, Barbara; Breningstall, Galen; Tohyama, Jun; Aoki, Yoko; Matsubara, Yoichi.

In: Human Mutation, Vol. 27, No. 4, 04.2006, p. 343-352.

Research output: Contribution to journalArticle

Kure, S, Kato, K, Dinopoulos, A, Gail, C, DeGrauw, TJ, Christodoulou, J, Bzduch, V, Kalmanchey, R, Fekete, G, Trojovsky, A, Plecko, B, Breningstall, G, Tohyama, J, Aoki, Y & Matsubara, Y 2006, 'Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia', Human Mutation, vol. 27, no. 4, pp. 343-352. https://doi.org/10.1002/humu.20293
Kure S, Kato K, Dinopoulos A, Gail C, DeGrauw TJ, Christodoulou J et al. Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia. Human Mutation. 2006 Apr;27(4):343-352. https://doi.org/10.1002/humu.20293
Kure, Shigeo ; Kato, Kumi ; Dinopoulos, Agirios ; Gail, Chuck ; DeGrauw, Ton J. ; Christodoulou, John ; Bzduch, Vladimir ; Kalmanchey, Rozalia ; Fekete, G. ; Trojovsky, Alex ; Plecko, Barbara ; Breningstall, Galen ; Tohyama, Jun ; Aoki, Yoko ; Matsubara, Yoichi. / Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia. In: Human Mutation. 2006 ; Vol. 27, No. 4. pp. 343-352.
@article{987d7bc388f542a9915a953875911f0e,
title = "Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia",
abstract = "Nonketotic hyperglycinemia (NKH) is an inborn error of metabolism characterized by accumulation of glycine in body fluids and various neurological symptoms. NKH is caused by deficiency of the glycine cleavage multi-enzyme system with three specific components encoded by GLDC, AMT and GCSH. We undertook the first comprehensive screening for GLDC, AMT and GCSH mutations in 69 families (56, six, and seven families with neonatal, infantile, and late-onset type NKH, respectively). GLDC or AMT mutations were identified in 75{\%} of neonatal and 83{\%} of infantile families, but not in late-onset type NKH. No GCSH mutation was identified in this study. GLDC mutations were identified in 36 families, and AMT mutations were detected in 11 families. In 16 of the 36 families with GLDC mutations, mutations were identified in only one allele despite sequencing of the entire coding regions. The GLDC gene consists of 25 exons. Seven of the 32 GLDC missense mutations were clustered in exon 19, which encodes the cofactor-binding site Lys754. A large deletion involving exon 1 of the GLDC gene was found in Caucasian, Oriental, and black families. Multiple origins of the exon 1 deletion were suggested by haplotype analysis with four GLDC polymorphisms. This study provides a comprehensive picture of the genetic background of NKH as it is known to date.",
keywords = "AMT, GCSH, Genotype-phenotype, GLDC, Glycine cleavage system, Glycine encephalopathy, Mutation spectrum, NKH, Nonketotic hyperglycinemia",
author = "Shigeo Kure and Kumi Kato and Agirios Dinopoulos and Chuck Gail and DeGrauw, {Ton J.} and John Christodoulou and Vladimir Bzduch and Rozalia Kalmanchey and G. Fekete and Alex Trojovsky and Barbara Plecko and Galen Breningstall and Jun Tohyama and Yoko Aoki and Yoichi Matsubara",
year = "2006",
month = "4",
doi = "10.1002/humu.20293",
language = "English",
volume = "27",
pages = "343--352",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia

AU - Kure, Shigeo

AU - Kato, Kumi

AU - Dinopoulos, Agirios

AU - Gail, Chuck

AU - DeGrauw, Ton J.

AU - Christodoulou, John

AU - Bzduch, Vladimir

AU - Kalmanchey, Rozalia

AU - Fekete, G.

AU - Trojovsky, Alex

AU - Plecko, Barbara

AU - Breningstall, Galen

AU - Tohyama, Jun

AU - Aoki, Yoko

AU - Matsubara, Yoichi

PY - 2006/4

Y1 - 2006/4

N2 - Nonketotic hyperglycinemia (NKH) is an inborn error of metabolism characterized by accumulation of glycine in body fluids and various neurological symptoms. NKH is caused by deficiency of the glycine cleavage multi-enzyme system with three specific components encoded by GLDC, AMT and GCSH. We undertook the first comprehensive screening for GLDC, AMT and GCSH mutations in 69 families (56, six, and seven families with neonatal, infantile, and late-onset type NKH, respectively). GLDC or AMT mutations were identified in 75% of neonatal and 83% of infantile families, but not in late-onset type NKH. No GCSH mutation was identified in this study. GLDC mutations were identified in 36 families, and AMT mutations were detected in 11 families. In 16 of the 36 families with GLDC mutations, mutations were identified in only one allele despite sequencing of the entire coding regions. The GLDC gene consists of 25 exons. Seven of the 32 GLDC missense mutations were clustered in exon 19, which encodes the cofactor-binding site Lys754. A large deletion involving exon 1 of the GLDC gene was found in Caucasian, Oriental, and black families. Multiple origins of the exon 1 deletion were suggested by haplotype analysis with four GLDC polymorphisms. This study provides a comprehensive picture of the genetic background of NKH as it is known to date.

AB - Nonketotic hyperglycinemia (NKH) is an inborn error of metabolism characterized by accumulation of glycine in body fluids and various neurological symptoms. NKH is caused by deficiency of the glycine cleavage multi-enzyme system with three specific components encoded by GLDC, AMT and GCSH. We undertook the first comprehensive screening for GLDC, AMT and GCSH mutations in 69 families (56, six, and seven families with neonatal, infantile, and late-onset type NKH, respectively). GLDC or AMT mutations were identified in 75% of neonatal and 83% of infantile families, but not in late-onset type NKH. No GCSH mutation was identified in this study. GLDC mutations were identified in 36 families, and AMT mutations were detected in 11 families. In 16 of the 36 families with GLDC mutations, mutations were identified in only one allele despite sequencing of the entire coding regions. The GLDC gene consists of 25 exons. Seven of the 32 GLDC missense mutations were clustered in exon 19, which encodes the cofactor-binding site Lys754. A large deletion involving exon 1 of the GLDC gene was found in Caucasian, Oriental, and black families. Multiple origins of the exon 1 deletion were suggested by haplotype analysis with four GLDC polymorphisms. This study provides a comprehensive picture of the genetic background of NKH as it is known to date.

KW - AMT

KW - GCSH

KW - Genotype-phenotype

KW - GLDC

KW - Glycine cleavage system

KW - Glycine encephalopathy

KW - Mutation spectrum

KW - NKH

KW - Nonketotic hyperglycinemia

UR - http://www.scopus.com/inward/record.url?scp=33645787595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645787595&partnerID=8YFLogxK

U2 - 10.1002/humu.20293

DO - 10.1002/humu.20293

M3 - Article

VL - 27

SP - 343

EP - 352

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 4

ER -